Kcentra (CSL Behring GmbH)
Welcome to the PulseAid listing for the Kcentra drug offered from CSL Behring GmbH. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring GmbH |
| NON-PROPRIETARY NAME: | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, Protein C, Protein S Human, and Water |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-04-29 |
| END MARKETING DATE: | 0000-00-00 |
Kcentra PLASMA DERIVATIVE Details:
| Item Description | Kcentra from CSL Behring GmbH |
| LABELER NAME: | CSL Behring GmbH |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2013-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63833-386_d5957e88-7434-4e3b-a035-224e2f9fca1f |
| PRODUCT NDC: | 63833-386 |
| APPLICATION NUMBER: | BLA125421 |